AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 36170581
Drug: Traditional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional physical therapy combined with pulsed local cryotherapy three times per week for 12 weeks
Trial: 36170581
Drug: Traditional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional physical therapy three times per week for 12 weeks
Trial: 33913678
Drug: PRD-guided remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRD-guided remifentanil administration
Trial: 32850394
Drug: Weekly TPF
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly TPF (Docetaxel, Cisplatin, Fluorouracil)
Trial: 32850394
Drug: 3-weekly TPF
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-weekly TPF (Docetaxel, Cisplatin, Fluorouracil)
Trial: 32850394
Drug: Weekly TPF
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly TPF
Trial: 38369221
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative therapy (SMT)
Trial: 35704292
Drug: Intravenous Vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Vitamin C (50 mg/kg every 6 hours for up to 96 hours)
Trial: 35704292
Drug: Intravenous Vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Vitamin C
Trial: 32986498
Drug: VenR with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VenR with undetectable minimal residual disease (uMRD) at end of combination therapy (EOCT)
Trial: 32986498
Drug: VenR followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VenR followed by ibrutinib as first therapy after progression
Trial: 34479838
Drug: apalutamide (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apalutamide (240 mg/d)
Trial: 36275396
Drug: Group R
RxNorm normalized name: Typhus group rickettsia Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group R (20 ml of 0.33% ropivacaine plus 1 ml normal saline)
Trial: 34125374
Drug: Radiation and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation and chemotherapy at diagnosis
Trial: 35726856
Drug: 0.3 g·kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g·kg‐1 dextrose, identified as creatine (Cr-True)
Trial: 35726856
Drug: 0.3 g·kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g·kg‐1 dextrose, identified as creatine (Cr-False)
Trial: 35726856
Drug: 0.3 g·kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g·kg‐1 dextrose placebo (PLC)
Trial: 33661967
Drug: 10% topical
RxNorm normalized name: BP 10% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% topical diclofenac
Trial: 34183350
Drug: Digital cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital cognitive-behavioural therapy for insomnia (dCBT-I)
Trial: 35218300
Drug: Immediate antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate antiretroviral therapy (ART) offered through trial clinics in intervention clusters
Trial: 36335970
Drug: Active eradication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active eradication (oral clarithromycin 500 mg, metronidazole 400 mg, and lansoprazole 30 mg, twice daily for 1 week)
Trial: 32650801
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injection (8 mL)
Trial: 32650801
Drug: Corticosteroid (CS)
RxNorm normalized name: MyoGesic-CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid (CS) injection (1 mL of 40 mg/mL triamcinolone acetonide plus 5 mL of 2% lidocaine)
Trial: 33099944
Drug: Chemotherapy (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (group A)
Trial: 32076917
Drug: Sofosbuvir/Daclatasvir (SOF/DCV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir/Daclatasvir (SOF/DCV) therapy
Trial: 34010505
Drug: Learning through
RxNorm normalized name: Noxzema Clean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Learning through Play Plus (LTP+) added to treatment as usual (TAU)
Trial: 34382931
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection then progressive exercise (n=182) (six or fewer physiotherapy sessions)
Trial: 34382931
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection then best-practice advice (n=178) (one physiotherapy session)
Trial: 33977839
Drug: RIPC C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIPC C (once daily for 4 weeks)
Trial: 33977839
Drug: RIPC D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIPC D (twice daily for 4 weeks)
Trial: 33977839
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no specific sham treatment)
Trial: 33594821
Drug: Intermittent TKI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent TKI treatment (1 month ON and 1 month OFF)
Trial: 34414903
Drug: ivabradine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine (5 mg)
Trial: 34414903
Drug: metoprolol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol (25 mg)
Trial: 34414903
Drug: ivabradine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine (5 mg) and metoprolol (25 mg) combination
Trial: 33351303
Drug: Testosterone Undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone Undecanoate Capsules (TUC) 40 mg, bid
Trial: 33351303
Drug: Jiarong Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiarong Tablets (JRT) + Testosterone Undecanoate Capsules (TUC) 0.92 g, tid
Trial: 32539487
Drug: Cognition test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognition test battery administered with a test-retest interval of ≥10 days
Trial: 32539487
Drug: Cognition test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognition test battery administered with a test-retest interval of ≤5 days
Trial: 32539487
Drug: Cognition test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognition test battery administered 4 times per day
Trial: 32212237
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg TID)
Trial: 36493691
Drug: Bilateral Electroconvulsive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral Electroconvulsive Therapy (ECT)
Trial: 36493691
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (Control)
Trial: 33245525
Drug: Dental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental treatment in the presence of a therapy dog
Trial: 35950596
Drug: Group exercise
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group exercise intervention (twice a week for eight weeks)
Trial: 32959058
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (ADE)
Trial: 34435439
Drug: Sugammadex (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (doses of 0.125, 0.25, 0.5, 1.0, or 2.0 mg/kg)
Trial: 33052757
Drug: Cisplatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (40 mg/m2 weekly during RT)
Trial: 33052757
Drug: Cetuximab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (400 mg/m2 1 week before RT followed by 250 mg/m2/wk during RT)
Trial: 33052757
Drug: Dose escalation
RxNorm normalized name: PALFORZIA Initial Dose Escalation KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose escalation in T3‐T4 tumors
Trial: 35841521
Drug: Split-dose PEG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose PEG
Trial: 33356686
Drug: Stepwise dose
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepwise dose reduction (DR)
Trial: 32215805
Drug: Apatinib mesylate
RxNorm normalized name: mesylate
DrugBank: Rivoceranib (DB14765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib mesylate 500–750 mg
Trial: 36316706
Drug: Logo-therapy intervention
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Logo-therapy intervention (4 sessions of 45-60 min, three times a week)
Trial: 36016767
Drug: Oral N-acetyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral N-acetyl cysteine
Trial: 32216490
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg daily vaginal progesterone
Trial: 32493502
Drug: Healthy behavior
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy behavior text messaging (daily)
Trial: 32493502
Drug: Blood pressure
RxNorm normalized name: Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure self‐monitoring (daily)
Trial: 36002117
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 5000 mg orally twice daily from D 285 until parturition
Trial: 36002117
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 5000 mg lactose orally once daily from D 120 until parturition
Trial: 33602439
Drug: Ticagrelor monotherapy
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor monotherapy after 3-month dual-antiplatelet therapy (DAPT)
Trial: 37063970
Drug: Ticagrelor monotherapy
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor monotherapy after 3-month DAPT
Trial: 35596166
Drug: Computer-controlled Intraligamentary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-controlled Intraligamentary anaesthesia (CC-ILA)
Trial: 34907594
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg Remimazolam Tosilate (R2)
Trial: 33973655
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg intravenous dose of raxibacumab over a period of 2.25 hours
Trial: 32886915
Drug: Non-aggressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-aggressive treatment for vasospasm
Trial: 35610353
Drug: Structured Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured Water Dance Intervention (SWAN), administered for 40 min once a week during a 12-week period.
Trial: 33345430
Drug: Sufficient 25(OH)D
RxNorm normalized name: 1α,25(OH)2D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufficient 25(OH)D levels (≥30 ng/mL)
Trial: 33831046
Drug: Tocilizumab 400
RxNorm normalized name: tocilizumab 400 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 400 mg
Trial: 33119467
Drug: 150 mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of fluconazole (EDHF inhibition)
Trial: 33119467
Drug: 500 mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of aspirin (prostaglandin inhibition)
Trial: 33516927
Drug: Indomethacin (IM)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (IM) oral spray
Trial: 35236061
Drug: Low-frequency magnet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency magnet therapy
Trial: 34587382
Drug: AZD1222 (ChAdOx1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1222 (ChAdOx1 nCoV-19) vaccine
Trial: 32462773
Drug: Zonisamide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zonisamide (400 mg)
Trial: 34162485
Drug: Warfarin (W)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (W)
Trial: 35513795
Drug: Low-25(OH)D-Calcitriol group
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-25(OH)D-Calcitriol group (calcitriol 0.25 µg bid)
Trial: 36208548
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT), 40 daily sessions
Trial: 36064261
Drug: Intracytoplasmic Sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic Sperm Injection (ICSI)
Trial: 35394687
Drug: Spirulina (5.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina (5.7 g day-1)
Trial: 34814585
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg hepatitis B vaccine
Trial: 32597821
Drug: Safe drug
RxNorm normalized name: Safe-Guard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safe drug management, error management, infection control, safe clinical services
Trial: 32940428
Drug: Telemedicine (TM)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telemedicine (TM) service based on mobile health (mHealth), including remote daily monitoring of biometric data and symptom reporting combined with videoconference structured, nurse-based follow-up.
Trial: 33787615
Drug: Pilates group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates group (P-G)
Trial: 33787615
Drug: General physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General physical activity program group (Pa-G)
Trial: 35623841
Drug: 6.3 g
RxNorm normalized name: OCTINOXATE 6.3 g in 100 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.3 g (Low) essential amino acid enriched whey protein supplement
Trial: 35623841
Drug: 12.6 g
RxNorm normalized name: BENZOYL PEROXIDE 12.6 g in 113 g TOPICAL SOAP [PanOxyl]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.6 g (High) essential amino acid enriched whey protein supplement
Trial: 34586711
Drug: Curcumin supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin supplementation (dose ≤1,000 mg/day)
Trial: 34586711
Drug: Curcumin consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin consumption (less than 2000 mg/day)
Trial: 33285707
Drug: Dexmedetomidine-propofol combination
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine-propofol combination (Group D)
Trial: 34560383
Drug: Cisplatin 30
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 30 mg/m2 with nimotuzumab once a week with curative radiotherapy
Trial: 34560383
Drug: Cisplatin 30
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 30 mg/m2 alone
Trial: 36282170
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg intravenous tranexamic acid (TXA) administered 15 min before incision in 100 cc of saline
Trial: 33109037
Drug: Desloratadine tablet
RxNorm normalized name: Desloratadine Tablets
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine tablet (5mg)
Trial: 35365713
Drug: Enema (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enema (maintenance dose delivery)
Trial: 33576545
Drug: Acetaminophen 650
RxNorm normalized name: acetaminophen 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 650 mg
Trial: 36189948
Drug: 140 mg
RxNorm normalized name: caffeine 140 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 140 mg erenumab
Trial: 33681652
Drug: Perampanel (2–12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perampanel (2–12 mg/day)
Trial: 36353577
Drug: Umbilical cord
RxNorm normalized name: Sus Scrofa Umbilical Cord
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umbilical cord blood infusion
Trial: 32471645
Drug: Zymomonas mobilis
RxNorm normalized name: Laurus nobilis
DrugBank: Laurus nobilis (DB10670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zymomonas mobilis fermented broth twice a day
Trial: 32471645
Drug: Cell-free fermented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell-free fermented broth once daily
Trial: 32471645
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline once daily)
Trial: 32319087
Drug: Rocuronium administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium administration
Trial: 34057705
Drug: 3 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g/day green cardamom
Trial: 34252289
Drug: 0.6 mg
RxNorm normalized name: thymol 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg dasiglucagon
Trial: 32727732
Drug: Free glasses
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free glasses and a teacher incentive (tablet computer if ≥80% of children given glasses were wearing them on un‐announced examination)
Trial: 32727732
Drug: Glasses prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glasses prescription and letter to parents
Trial: 38178229
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D
Trial: 36367720
Drug: Extended run-in
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended run-in varenicline treatment (4 weeks before quitting)
Trial: 34342754
Drug: Self-administered gut-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered gut-directed hypnosis intervention (7 bi-weekly audio sessions over 3 months)
Trial: 34342754
Drug: Self-administered gut-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered gut-directed hypnosis intervention
Trial: 34521576
Drug: Peer-led theory-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer-led theory-based oral health intervention
Trial: 34521576
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (booklets for oral health promotion)
Trial: 33131932
Drug: Post F-subunit
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post F-subunit vaccine
Trial: 33007285
Drug: Intravenous antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotics (ceftazidime and tobramycin for 14 days combined with inhaled colistimethate sodium for 12 weeks)
Trial: 34836350
Drug: Insulin levels
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin levels in all conditions vs Sucralose
Trial: 32215888
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of 200 μg 25OHD followed by daily infusion of 15 μg 25OHD for 10 days
Trial: 34857853
Drug: Carprofen 4.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carprofen 4.4 mg/kg/day for 90 days
Trial: 34857853
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no anti-inflammatory medication)
Trial: 32325373
Drug: macimorelin 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: macimorelin 0.5 mg/kg
Trial: 32325373
Drug: macimorelin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: macimorelin 1.0 mg/kg
Trial: 32325373
Drug: macimorelin 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: macimorelin 2.0 mg/kg
Trial: 34850166
Drug: Post-treatment biopsies
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment biopsies
Trial: 36164180
Drug: Belantamab mafodotin
RxNorm normalized name: belantamab mafodotin
DrugBank: Belantamab mafodotin (DB15719)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Belantamab mafodotin 2.5 mg/kg Q3W (Arm A)
Trial: 36164180
Drug: Belantamab mafodotin
RxNorm normalized name: belantamab mafodotin
DrugBank: Belantamab mafodotin (DB15719)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Belantamab mafodotin 1.9 mg/kg Q3W (Arm B)
Trial: 36164180
Drug: Belantamab mafodotin
RxNorm normalized name: belantamab mafodotin
DrugBank: Belantamab mafodotin (DB15719)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Belantamab mafodotin 1.9 mg/kg Q6W (Arm D)
Trial: 36164180
Drug: Belantamab mafodotin
RxNorm normalized name: belantamab mafodotin
DrugBank: Belantamab mafodotin (DB15719)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Belantamab mafodotin 1.9 mg/kg Q6W (Arm E)
Trial: 34098672
Drug: Placebo vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo vitamin C 100 mg
Trial: 33545945
Drug: Pestle needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pestle needle therapy
Trial: 32798197
Drug: Control (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (sham treatment with very light pressure)